Histopathology of American Kestrels (Falco sparverius) Exposed to Two Brodifacoum Isomer Formulations with Differing Elimination Half-Lives
Dates
Publication Date
2024-03-29
Start Date
2024-01-02
End Date
2024-01-17
Citation
Lankton, J.S., and Rattner, B.A., 2024, Histopathology of American Kestrels (Falco sparverius) Exposed to Two Brodifacoum Isomer Formulations with Differing Elimination Half-Lives: U.S. Geological Survey data release, https://doi.org/10.5066/P1UMMZQV.
Summary
This dataset documents histopathological changes in liver, kidney, skeletal muscle and intestine of captive American kestrels (Falco sparverius) exposed to brodifacoum formulations with differing elimination half-lives in target rodents. The toxicity of two brodifacoum formulations with stereoisomers having markedly different elimination half-lives in rats (Formulation A containing the 2 least persistent stereoisomers, Formulation B containing the most persistent stereoisomer) were tested in a 7-day dietary feeding trial. Based on previous kestrel studies using commercially available brodifacoum, Formulations A and B were each provided at 3 dietary concentrations (0.05, 0.1 and 0.5 µg/g diet, 4 kestrels/dose level) predicted to cause [...]
Summary
This dataset documents histopathological changes in liver, kidney, skeletal muscle and intestine of captive American kestrels (Falco sparverius) exposed to brodifacoum formulations with differing elimination half-lives in target rodents. The toxicity of two brodifacoum formulations with stereoisomers having markedly different elimination half-lives in rats (Formulation A containing the 2 least persistent stereoisomers, Formulation B containing the most persistent stereoisomer) were tested in a 7-day dietary feeding trial. Based on previous kestrel studies using commercially available brodifacoum, Formulations A and B were each provided at 3 dietary concentrations (0.05, 0.1 and 0.5 µg/g diet, 4 kestrels/dose level) predicted to cause a range of toxicity. Birds were necropsied and examined grossly for hemorrhages or anemia, and liver, kidney, skeletal muscle, and intestine was collected for histopathological evaluation. Tissues stained by hematoxylin and eosin were scanned at at least 100x magnification and all hemorrhage, defined as erythrocyte extravasation, was scored on a severity scale of 0-4 (absent, minimal, mild, moderate, or severe). Other microscopic abnormalities noted within the case set were scored as absent or present. Microscopic examination revealed mild to moderate hemorrhage in 11/111 of tissues examined, including samples from the control group; hemorrhage was not related to dietary concentration of either brodifacoum formulation. Other observations in the case set included portal infiltrates in the liver (27/27), suspect polyomavirus inclusions in the kidney (14/28), renal interstitial lymphoplasmacytic infiltrates (6/28), other cellular infiltrates (17/111), myocyte degeneration or regeneration (3/28), myocellular protozoal cysts (2/28), hepatocellular glycogenosis (1/27), and minimal hepatocellular necrosis (1/27). These findings are not considered likely to be clinically significant or related to brodifacoum exposure.
Click on title to download individual files attached to this item.
Lankton_kestrels_metadata.xml Original FGDC Metadata
View
23.11 KB
application/fgdc+xml
2023 kestrels final results 3.27.24.csv
5.68 KB
text/csv
Purpose
The data were collected to help determine the relative toxicity of brodifacoum with low or high elimination half-lives in a non-target raptor species. The data will be combined with other indicators of toxicity such as hematocrit, prothrombin time, and Russell’s viper venom time.
